1,051
Participants
Start Date
March 21, 2017
Primary Completion Date
October 4, 2018
Study Completion Date
October 4, 2018
V114 Lot 1
Lot 1: Pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19F, 19A, 22F, 23F, 33F (2 mcg each), and serotype 6B (4 mcg) in each 0.5 mL dose
V114 Lot 2
Lot 2: Pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19F, 19A, 22F, 23F, 33F (2 mcg each), and serotype 6B (4 mcg) in each 0.5 mL dose
Prevnar 13™
Pneumococcal capsular polysaccharide serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F (2.2 mcg) and 6B (4.4 mcg) in each 0.5 ml dose
Child Health Care Associates ( Site 0064), East Syracuse
State University of New York Upstate Medical University ( Site 0065), Syracuse
Kid's Way Pediatrics ( Site 0036), Hermitage
Thomas Jefferson University ( Site 0067), Philadelphia
Pediatric Medical Associates ( Site 0059), East Norriton
Pediatric Research of Charlottesville, LLC ( Site 0066), Charlottesville
Huguenot Pediatrics ( Site 0057), Midlothian
Coastal Pediatric Research ( Site 0070), Charleston
Birmingham Pediatric Research ( Site 0043), Birmingham
Southeastern Pediatric Associates, P.A. ( Site 0079), Dothan
Holston Medical Group [Kingsport, TN] ( Site 0048), Kingsport
Kentucky Pediatric/Adult Research Inc ( Site 0037), Bardstown
University of Louisville: Pediatric Clinical Trials Unit ( Site 0049), Louisville
Senders Pediatrics ( Site 0058), Cleveland
Pediatric Associates of Mt. Carmel, Inc. ( Site 0052), Cincinnati
Ohio Pediatric Research Association ( Site 0060), Dayton
Dundee Clinic ( Site 0063), Omaha
ACC Pediatric Research ( Site 0039), Haughton
Children's Clinic of Jonesboro, PA ( Site 0054), Jonesboro
University of Texas Medical Branch at Galveston ( Site 0056), Galveston
University of Texas Medical Branch at Galveston ( Site 0068), League City
Wee Care Pediatrics ( Site 0042), Layton
Copperview Medical Center ( Site 0062), South Jordan
Cottonwood Pediatrics ( Site 0041), Murray
Premier Health Research Center, LLC ( Site 0035), Downey
Sherif Khamis MD, Inc. ( Site 0044), Palmdale
Kaiser Permanente - Roseville ( Site 0045), Roseville
Kaiser Permanente Clinical Trial - Sacramento ( Site 0076), Sacramento
Family Health Care of Ellensburg ( Site 0077), Ellensburg
Woburn Pediatric Associates ( Site 0046), Woburn
CHU Ste-Justine ( Site 0084), Montreal
McGill University Health Centre - Vaccine Study Centre ( Site 0030), Pierrefonds
CHU de Quebec Universite de Laval ( Site 0031), Québec
Aarhus Universitetshospital-Skejby-Forskningsklinikken for Kvindesygdomme ( Site 0025), Aarhus N
OUH Klinisk Forsk center Gyn Obs D. ( Site 0024), Odense
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007), Espoo
Tampereen yliopisto Etela-Helsingin rokotetutkimusklinikka ( Site 0005), Helsinki
Tampereen yliopisto Ita-Helsingin rokotetutkimusklinikka ( Site 0006), Helsinki
Tampereen yliopisto Järvenpään rokotetutkimusklinikka ( Site 0003), Järvenpää
Tampereen yliopisto Oulun rokotetutkimusklinikka ( Site 0004), Oulu
Tampereen yliopisto Porin rokotetutkimusklinikka ( Site 0008), Pori
Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001), Tampere
Tampereen yliopisto Turun rokotetutkimusklinikka ( Site 0002), Turku
Soroka University Medical Center ( Site 0019), Beersheba
Soroka University Medical Center - Rahat Family health center ( Site 0020), Beersheba
Soroka University Medical Center - Ramot Family health center ( Site 0021), Beersheba
Soroka University Medical Center - Vav Family health center ( Site 0022), Beersheba
Hospital Clinico Universitario de Santiago ( Site 0016), Santiago de Compostela
Unidad de Estudios e Investigacion IHP ( Site 0017), Seville
Merck Sharp & Dohme LLC
INDUSTRY